A compound represented by the structural formula
and pharmaceutically acceptable salts and solvents thereof is disclosed, wherein:
the single-dashed line
between the ring carbons to which R
10
and R
34
are attached represents either a single bond or a double bond;
the double-dashed line
between X and the carbon to which Y is attached represents either a single bond or an absent bond;
X is —O— or —NR
6
— when the double-dashed line represents a single bond; X is H, —OH or —NHR
20
when the double-dashed line represents an absent bond; and other parameters are as defined herein. Also disclosed are pharmaceutical compositions and combinations containing said compounds and their uses as thrombin receptor antagonists and binders to cannabinoid receptors.
揭示了一种由结构式表示的化合物及其在药学上可接受的盐和溶剂,其中:连接R10和R34附着的环碳之间的单虚线代表单键或双键;连接X和附着Y的碳之间的双虚线代表单键或缺失键;当双虚线代表单键时,X为—O—或—NR6—;当双虚线代表缺失键时,X为H、—OH或—NHR20;其他参数如本文所定义。还揭示了含有该化合物的药物组合物和药物组合物,以及它们作为凝血酶受体拮抗剂和
大麻素受体结合物的用途。